NBIX - Neurocrine Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 5/21/2020
Current
3/31/202012/31/20199/30/20196/30/20193/31/2019
Market Cap (intraday) 5
11.53B8.03B9.92B8.30B7.71B8.04B
Enterprise Value 3
11.26B7.86B9.73B8.14B7.64B7.78B
Trailing P/E
65.35221.92488.59474.26N/A400.45
Forward P/E 1
38.7631.1530.6722.88N/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
13.6110.5115.1714.3115.5918.62
Price/Book (mrq)
16.4612.6117.2617.1518.8816.73
Enterprise Value/Revenue 3
12.7033.1439.8636.6641.6456.21
Enterprise Value/EBITDA 6
49.32159.69199.07118.94123.65-83.50

Trading Information

Stock Price History

Beta (5Y Monthly) 1.26
52-Week Change 357.12%
S&P500 52-Week Change 35.46%
52 Week High 3127.28
52 Week Low 372.14
50-Day Moving Average 3104.30
200-Day Moving Average 3103.02

Share Statistics

Avg Vol (3 month) 3886.1k
Avg Vol (10 day) 31.02M
Shares Outstanding 592.87M
Float 91.62M
% Held by Insiders 11.04%
% Held by Institutions 199.05%
Shares Short (Apr 29, 2020) 45.09M
Short Ratio (Apr 29, 2020) 46.95
Short % of Float (Apr 29, 2020) 45.56%
Short % of Shares Outstanding (Apr 29, 2020) 45.49%
Shares Short (prior month Mar 30, 2020) 45.08M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 28, 1995
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 19.91%
Operating Margin (ttm)30.83%

Management Effectiveness

Return on Assets (ttm)14.73%
Return on Equity (ttm)31.82%

Income Statement

Revenue (ttm)886.79M
Revenue Per Share (ttm)9.64
Quarterly Revenue Growth (yoy)71.30%
Gross Profit (ttm)580.62M
EBITDA 281.31M
Net Income Avi to Common (ttm)176.51M
Diluted EPS (ttm)1.82
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)771.7M
Total Cash Per Share (mrq)8.31
Total Debt (mrq)508.5M
Total Debt/Equity (mrq)72.61
Current Ratio (mrq)6.90
Book Value Per Share (mrq)7.55

Cash Flow Statement

Operating Cash Flow (ttm)302.75M
Levered Free Cash Flow (ttm)224.85M